Ezetimibe NDC 71335-0933

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-0933Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-0933Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-0933-1	71335093301	30 TABLET in 1 BOTTLE (71335-0933-1)Marketed from Aug 23, 2018
71335-0933-2	71335093302	90 TABLET in 1 BOTTLE (71335-0933-2)Marketed from Jul 31, 2018
71335-0933-3	71335093303	28 TABLET in 1 BOTTLE (71335-0933-3)Marketed from Dec 28, 2021
71335-0933-4	71335093304	18 TABLET in 1 BOTTLE (71335-0933-4)Marketed from Dec 28, 2021
71335-0933-5	71335093305	60 TABLET in 1 BOTTLE (71335-0933-5)Marketed from Dec 28, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ezetimibe
Generic name (nonproprietary): ezetimibe
Active ingredients: Ezetimibe — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200831
Marketing start: Jun 12, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Cholesterol Absorption (Physiologic effect)
Identifiers: Product ID 71335-0933_4b23230f-2852-4daa-a5d8-45b5da0fb63eSPL ID 4b23230f-2852-4daa-a5d8-45b5da0fb63eSPL set ID 11828685-dc27-42d8-a6ff-f110018207d1RxCUI 349556UNII EOR26LQQ24
Pharmacologic class: Dietary Cholesterol Absorption Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335093301 followed by a unit qualifier and the quantity

Package 71335-0933-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 4, 2024.

Indications (excerpt from the label)

Ezetimibe tablets are indicated: In combination with a statin, or alone when additional low-density lipoprotein cholesterol (LDL-C) lowering therapy is not possible, as an adjunct to diet to reduce elevated LDL-C in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH). In combination with a statin as an adjunct to diet to reduce elevated LDL-C in pediatric patients 10 years of age and older with HeFH. In combination with fenofibrate as an adjunct to diet to reduce elevated LDL-C in adults with mixed hyperlipidemia. In combination with a statin, and other LDL-C lowering therapies, to reduce elevated LDL-C levels in adults and in pediatric patients 10…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)